Stroke Association
1 Sterling Business Park, Salthouse Road, Northampton, Northamptonshire, NN4 7EX, United Kingdom
Overview
Stroke Association is stroke is one of the most serious health problems of our day, but it receives far less attention and financing than cancer and heart disease. People are thinking about this deadly disease. But not able to do it on our own. They need to collaborate with people who share our dedication to transforming the world for people who have had a stroke, including decision makers, researchers, and clinicians, as well as our supporters.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Charity
- Health Care
- Hospitality
- Personal Health
Investment portfolio
- Upfront Diagnostics
Participated · Seed · Jun 2023
Upfront Diagnostics is a Cambridge-based healthcare company focused on discovering novel biomarkers for medical diagnosis. It has developed LVOne, a point-of-care rapid blood test designed to detect large vessel occlusion (LVO) strokes within 15 minutes to help paramedics and community health professionals identify stroke out of hospital. LVOne was validated on 270 patients at the Royal Victoria Infirmary Hospital in Newcastle. The company intends to use the £1.6m seed funding to scale its technology, improve the test's accuracy for identifying large artery strokes, expand its team and prepare for clinical approval. Detecting LVO in the ambulance allows patients to be fast-tracked to thrombectomy-specialized hospitals for rapid imaging and surgical intervention, which can save lives and reduce severity of disability. Development of the test has been supported by Innovate UK, Newcastle University, the Academic Health Science Network, NIHR, SBRI Healthcare, the Stroke Association and NHS Foundation Trust.
Team
No current team members are available.